Drawing for PHARMACOMM

USPTO serial 85289893

PHARMACOMM

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BHANOT, KAPIL KUMAR
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PHARMACOMM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael R. Friscia

Michael R. Friscia McCarter & English, LLP100 Mulberry StreetFour Gateway CenterNewark, NJ 07102

Goods and services

ClassDescriptionStatusFirst use
041Educational services, namely, conducting seminars and conferences on issues related to communication throughout the pharmaceutical development and regulatory process and distributing course materials in connection therewithACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Dec 8, 2014MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 8, 2014ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 14, 2014EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 13, 2014EX5GSOU EXTENSION 5 GRANTED—
May 1, 2014EXT5SOU EXTENSION 5 FILED—
May 1, 2014EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 14, 2013EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 13, 2013EX4GSOU EXTENSION 4 GRANTED—
Nov 1, 2013EXT4SOU EXTENSION 4 FILED—
Nov 1, 2013EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 31, 2013ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 31, 2013REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 30, 2013TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 3, 2013EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 2, 2013EX3GSOU EXTENSION 3 GRANTED—
Apr 29, 2013EXT3SOU EXTENSION 3 FILED—
Apr 29, 2013EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 7, 2012EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 6, 2012EX2GSOU EXTENSION 2 GRANTED—
Nov 5, 2012AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 1, 2012EXT2SOU EXTENSION 2 FILED—
Nov 1, 2012EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 12, 2012EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 10, 2012EX1GSOU EXTENSION 1 GRANTED—
Apr 10, 2012EXT1SOU EXTENSION 1 FILED—
Apr 10, 2012EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 1, 2011NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 6, 2011NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 6, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 1, 2011PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 1, 2011ALIEASSIGNED TO LIE—
Jul 28, 2011ALIEASSIGNED TO LIE—
Jul 12, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 12, 2011XAECEXAMINER'S AMENDMENT ENTERED—
Jul 12, 2011GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 12, 2011GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 12, 2011CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 12, 2011DOCKASSIGNED TO EXAMINER—
Apr 15, 2011MPMKNOTICE OF PSEUDO MARK MAILED—
Apr 14, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 12, 2011NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance